Clinical outcomes at 12 months and risk of inflammatory bowel disease in patients with an intermediate raised fecal calprotectin: a 'real-world' view.
- Resource Type
- Article
- Source
- BMJ Open; 6/6/2016, Vol. 6 Issue 6, p1-6, 6p
- Subject
- Language
- ISSN
- 20446055